McNeil Exec Calls For Uniform Use Of "Acetaminophen" Name
This article was originally published in The Tan Sheet
Executive Summary
Requiring all acetaminophen product labels to include the drug name, not an abbreviation, will help assure consumers know when an OTC or Rx drug contains the ingredient, says an executive with the manufacturer of the market-leading Tylenol line
You may also be interested in...
Umbrella Brand Debate Lives On At FDA Naming Workshop
Critics of drug labels' effectiveness say reducing errors in the use of OTC drugs depends largely on a change manufacturers oppose - reining in umbrella branding
Drug Industry Avoids FDA's "Blunt Tools" With Safe Use Initiative Progress
Efforts by firms and other pharmaceutical industry stakeholders to drive FDA's Safe Use Initiative agenda lower the likelihood of the agency intervening with enforcement action, according to Principal Deputy Commissioner Josh Sharfstein
McNeil Proposes Tylenol Label Change To Keep 1,000-MG Dose Available OTC
In a bid to keep 500-mg tablets and 1,000-mg doses of acetaminophen available over the counter, McNeil Consumer Healthcare argues revised dosing instructions would address the root cause of unintentional overdose without unduly restricting access to the popular painkiller